abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) announced a quarterly dividend on Monday, May 11th. Shareholders of record on Thursday, May 21st will be given a dividend of 0.56 per share on Saturday, May 30th. This represents a c) dividend on an annualized basis and a yield of 12.3%. The ex-dividend date is Thursday, May 21st.
abrdn Life Sciences Investors Price Performance
NYSE:HQL opened at $18.14 on Tuesday. The business’s 50-day simple moving average is $16.98 and its two-hundred day simple moving average is $16.98. abrdn Life Sciences Investors has a 52 week low of $11.92 and a 52 week high of $18.46.
About abrdn Life Sciences Investors
abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.
The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.
Featured Stories
- Five stocks we like better than abrdn Life Sciences Investors
- Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
Receive News & Ratings for abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.
